Results 201 to 210 of about 39,993 (263)

EEG network reorganization across Alzheimer's disease, frontotemporal dementia, and dementia with Lewy bodies. [PDF]

Alzheimers Dement (Amst)
Benussi A, Cantoni V, Palacino F, Altomare D, Moretti DV, Manganotti P, Borroni B.   +6 more
europepmc   +1 more source

Comorbid Pathologies and Their Impact on Dementia with Lewy Bodies-Current View. [PDF]

Int J Mol Sci
Jellinger KA.
europepmc   +1 more source

Discriminative Plasma Lipidomic Signatures of Dementia with Lewy Bodies and Alzheimer's Disease: A Targeted Mass Spectrometry and Machine Learning Approach. [PDF]

Neuropsychiatr Dis Treat
Wen L, Zhang Y, Nie Y, Shen H, Qin Q, Qu M.   +5 more
europepmc   +1 more source

Association of Plasma Amyloid, P-Tau, GFAP, and NfL With CSF, Clinical, and Cognitive Features in Patients With Dementia With Lewy Bodies

Blujdea, Elena R., Gonzalez, Maria C., Aarsland, Dag, Bonanni, Laura, for the European-Dementia With Lewy Bodies (E-DLB) Consortium, van Unnik, Annemartijn A.J.M., Zetterberg, Henrik, Bolsewig, Katharina, Mollenhauer, Brit, Ashton, Nicholas J., Padovani, Alessandro, Lemstra, Afina W.   +11 more
core   +1 more source

Theta burst stimulation for depressive symptoms in early-stage dementia with Lewy bodies: Protocol for a single-arm open-label feasibility study (DL-TBS Study). [PDF]

PCN Rep
Takahashi S, Satake Y, Hata M, Omori H, Hosomi K, Ikeda M.   +5 more
europepmc   +1 more source

Deep learning for FDG-PET classification in patients with Alzheimer's disease, dementia with Lewy bodies and their mixed pathology: a solution for diagnostic heterogeneity. [PDF]

Front Aging Neurosci
Kim S, Jeon S, Cho K, Kang S, Bang S, Ye BS, Lee JM.   +6 more
europepmc   +1 more source

Implication of dopamine transporter and electroencephalography biomarkers in dementia with lewy bodies. [PDF]

Sci Rep
Baik K, Jeon S, Kang S, Kim Y, Kim KM, Heo K, Yun M, Ye BS.   +7 more
europepmc   +1 more source